Who is sponsoring NCT05564481?

NCT05564481 is sponsored by Children's National Research Institute.

What drugs are being tested in NCT05564481?

Interventions in NCT05564481: diabetes education and parent coaching support.

What condition does NCT05564481 study?

NCT05564481 studies Type 1 Diabetes, Continuous Glucose Monitoring, Behavioral Intervention, Parent-Child Relations.

Is NCT05564481 still recruiting?

NCT05564481 is currently active, enrolled. Last updated 3 July 2025.

Last reviewed 2025-07-03 · How we verify

NCT05564481: ROUTE-T1D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Research on Optimizing the Use of Technology With Education

Active, enrolled NA Last updated 3 July 2025

What this trial tests

NA trial testing diabetes education and parent coaching support in Type 1 Diabetes in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 January 2022

Primary endpoint
1 January 2025

1 December 2026

Quick facts

Lead sponsor	Children's National Research Institute
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 January 2022
Primary completion	1 January 2025
Estimated completion	1 December 2026
Sites	1 location across United States

Drugs / interventions tested

diabetes education and parent coaching support

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →
Continuous Glucose Monitoring — all drugs for Continuous Glucose Monitoring →
Behavioral Intervention — all drugs for Behavioral Intervention →
Parent-Child Relations — all drugs for Parent-Child Relations →

Sponsor

Children's National Research Institute

Who can join

Adults 10 to 15, any sex, with Type 1 Diabetes or Continuous Glucose Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Consistent use of continuous glucose monitors (CGM) has the potential to improve glycemic control and related type 1 diabetes (T1D) health outcomes, however young adolescents with T1D are the least likely age group to begin and sustain use of CGM. The proposed study will conduct a feasibility trial of a behavioral intervention designed to optimize use of CGM in adolescents specifically targeting underrepresented populations in diabetes technology research.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development.
Straton E, Bryant BL, Kang L, Wang C, et al · · 2024 · cited 3× · PMID 38460913 · DOI 10.1016/j.cct.2024.107493

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Children's National Research Institute trials

Trials by the same sponsor.

NCT07336264 — Characterization of Acute Pain · recruiting
NCT06938542 — Palliative Care Needs of Children With Rare Diseases and Their Families · NA · enrolling by invitation
NCT06618027 — Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes · NA · recruiting
NCT06770010 — Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease · NA · recruiting
NCT06623981 — The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05564481 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's National Research Institute
Last refreshed: 3 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05564481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing